This grant supports research to develop in vitro or ex vivo assays and perform iterative screening to identify and characterize potential therapeutic agents targeting neurological or neuromuscular disorders. It aims to advance projects to meet criteria for translational programs like the Blueprint Neurotherapeutics Network. Clinical trials are not allowed under this funding.
Eligible applicants include federally recognized Native American tribal governments, public and state-controlled higher education institutions, small businesses, nonprofits, for-profit organizations, various government entities, and other specified organizations including tribal and minority-serving
